Dietary pattern, colonic microbiota and immunometabolism interaction: new frontiers for diabetes mellitus and related disorders
Eslami M, Bahar A, Hemati M, et al.
Diabet Med. Pub. online 6 October 2020
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
An early-onset subgroup of type 2 diabetes: a multigenerational, prospective analysis in the framingham heart study
Echouffo-Tcheugui JB, Niiranen TJ, McCabe EL, et al.
Diabetes Care. Pub. online 8 October 2020
Leggi
Updated meta-analysis assessing the effect of sodium-glucose co-transporter-2 inhibitors on surrogate endpoints in patients with heart failure with reduced ejection fraction
Patoulias D, Papadopoulos C, Kalogirou MS, et al.
The American Journal of Cardiology. Pub. online 10 October 2020
Leggi
Meta-analysis of dedicated renal outcome trials assessing the cardio-renal efficacy of sodium-glucose co-transporter-2 inhibitors in patients with chronic kidney disease and albuminuria
Patoulias D, Papadopoulos C, Stavropoulos K, et al.
The American Journal of Cardiology. Pub. online 8 October 2020
Leggi
Diabetic retinopathy and risk of stroke. A secondary analysis of the ACCORD Eye study
Wong KH, Hu K, Peterson C, et al.
Stroke. Pub. online 6 October 2020
Leggi
Chrono-nutrition for the prevention and treatment of obesity and type 2 diabetes: from mice to men
Hawley JA, Sassone-Corsi P, Zierath JR
Diabetologia. 2020;63(11):2253-2259
Leggi
Metabolic phenotypes of early gestational diabetes mellitus and their association with adverse pregnancy outcomes
Immanuel J, Simmons D, Harreiter J, et al.
Diabet Med. Pub. online 29 September 2020
Leggi
Efficacy and safety of endothelin receptor antagonists in type 2 diabetic kidney disease: a systematic review and meta‐analysis of randomized controlled trials
Zhou Y, Chi J, Huang Y, et al.
Diabet Med. Pub. online 30 September 2020
Leggi
Association of early-onset diabetes, prediabetes and early glycaemic recovery with the risk of all-cause and cardiovascular mortality
Kim SM, Lee G, Choi S, et al.
Diabetologia. 2020;63(11):2305-2314
Leggi
Effects of once-weekly subcutaneous semaglutide on kidney function and safety in patients with type 2 diabetes: a post-hoc analysis of the SUSTAIN 1–7 randomised controlled trials
Mann JFE, Hansen T, Idorn T, et al
Lancet Diabetes Endocrinol. 2020;S2213-8587(20)30313-2
Leggi